earticle

영어

Biotechnology industry have been spending huge amount of time and money on R&D. Furthermore there are some types of approval systems which are necessarily required for commercialization. Therefore, patent is especially important as a legal instrument for protection of technology in Biotechnology industry nowadays. This study is to find out how patenting strategies affect company performance in Korea biotechnology industry and to induce main issues from analysis related to question, “What do we supposed to consider while trying to making patent strategies.” For such, we used patent-related and financial information of 118 companies in Korea biotechnology industry. In particular, this study tries to apply the patent strategy model of Ernst(1995) on Korea biotechnology industry and to do empirical analysis on the degree of company performance affected by various patenting strategies. As a result of study, Korea biotechnology industries are supposed to be classified into pharmaceutical companies which have high patent activity(Active Patentees) and other pharmaceutical companies which have low patent activity(Inactive Patentees), and NBFs(New Biotechnology Firms) in bio industry which perform patent activity selectively(Selective Patentees). There is difference in company performance by types of patent strategies. NBFs have much benefit more than pharmaceutical companies whose patent activity is low. It means that patent management is needed in Biotechnology industry.